A Topical Treatment Optimization Programme (TTOP) improves clinical outcome for calcipotriol/betamethasone gel in psoriasis: results of a 64-week multinational randomized phase IV study in 1790 patients (PSO-TOP)-Reference-Cited by-同舟云学术

A Topical Treatment Optimization Programme (TTOP) improves clinical outcome for calcipotriol/betamethasone gel in psoriasis: results of a 64-week multinational randomized phase IV study in 1790 patients (PSO-TOP)

Published:2017-06-06 Issue:1 Volume:177 Page:197-205
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Reich K.¹²^ORCID,Zschocke I.²,Bachelez H.³,de Jong E.M.G.J.⁴,Gisondi P.⁵^ORCID,Puig L.⁶^ORCID,Warren R.B.⁷,Ortland C.⁸,Mrowietz U.⁹,

Affiliation:

1. Dermatologikum Hamburg; Hamburg Germany

2. SCIderm GmbH; Hamburg Germany

3. Sorbonne Paris Cité Université Paris-Diderot; AP-HP Hôpital Saint-Louis; Paris France

4. Radboud University Medical Centre and Radboud University; Nijmegen the Netherlands

5. Dermatology and Venerology Section; University of Verona; Verona Italy

6. Department of Dermatology; Hospital de la Santa Creu i Sant Pau; Universitat Autònoma de Barcelona; Barcelona Spain

7. The Dermatology Centre; Salford Royal NHS Foundation Trust; The University of Manchester; Manchester Academic Health Science Centre; Manchester U.K.

8. Das Forschungsdock Service for Clinical Development; Schenefeld Germany

9. Psoriasis Center; Department of Dermatology; University Medical Center Schleswig-Holstein; Campus Kiel; Kiel Germany

Funder

LEO Pharma Research Foundation

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.15466/fullpdf

Reference27 articles.

1. World Health Organization Adherence to long-term therapies. Evidence for action 2003 http://whqlibdoc.who.int/publications/2003/9241545992.pdf